A phase I study of the safety, Pharmacokinetics, and Pharmacodynamics of combination therapy with refametinib plus sorafenib in patients with advanced cancer

Alex A. Adjei, Donald A. Richards, Anthony El-Khoueiry, Fadi Braiteh, Carlos H.R. Becerra, Joe J.Stephenson Jr, Aram F. Hezel, Morris Sherman, Lawrence Garbo, Diane P. Leffingwell, Cory Iverson, Jeffrey N. Miner, Zancong Shen, Li Tain Yeh, Sonny Gunawan, David M. Wilson, Kimberly J. Manhard, Prabhu Rajagopalan, Heiko Krissel, Neil J. Clendeninn

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I study of the safety, Pharmacokinetics, and Pharmacodynamics of combination therapy with refametinib plus sorafenib in patients with advanced cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences